Table 5.
Site | gen | LSS12 ERR1b | 2-p ERR1,φc | φmd | trans ERR1,φe | φmf |
Stomach | M/F | 0.0024 (0.001, 0.004) | 0.46 (0.11, 0.94) | 11.89 | 0.00 (-0.06, 0.16) | 11.85 |
M | 0.001 (-0.0005, 0.0028) | 2.68 (-0.15, 32.45) | 6.14 | 0.00 (-0.21, 0.17) | 21.77 | |
F | 0.0047 (0.0022, 0.0077) | 0.80 (0.15, 1.77) | 13.67 | 0.43 (0.00, 0.96) | 13.68 | |
Liver | M/F | 0.0037 (0.0013, 0.0065) | 1.43 (0.48, 2.95) | 36.90 | 0.95 (0.28, 1.99) | 36.90 |
M | 0.0048 (0.0017, 0.0088) | 1.72 (0.40, 4.25) | 36.97 | 1.30 (0.28, 3.10) | 36.97 | |
F | 0.0019 (-0.0011, 0.0062) | 1.24 (0.06, 3.60) | 36.90 | 1.09 (0.15, 2.78) | 38.55 | |
Lung | M/F | 0.0053 (0.0028, 0.0084) | 0.88 (0.12, 3.36) | 13.60 | 0.80 (0.19, 1.99) | 13.60 |
M | 0.0034 (0.0006, 0.0069) | 0.78 (-0.11, 4.91) | 13.55 | 0.74 (0.05, 2.40) | 13.55 | |
F | 0.0089 (0.0041, 0.0151) | 1.35 (0.07, 4.83) | 21.91 | 1.04 (0.09, 3.28) | 21.91 | |
Colon | M/F | 0.0065 (0.0023, 0.0121) | 0.05 (-0.53, 1.15) | 20.28 | 0.07 (-0.49, 1.71) | 43.98 |
M | 0.0048 (-0.0002, 0.0127) | 0.30 (-0.59, 3.16) | 28.63 | 0.40 (-0.50, 2.72) | 28.63 | |
F | 0.0081 (0.0022, 0.0077) | 0.47 (-0.55, 2.96) | 41.62 | 0.29 (-0.78, 2.26) | 41.62 | |
Uterus | F | 0.0024 (-0.0006, 0.0067) | 0.47 (-0.32, 2.12) | 26.91 | 0.000 (-0.23, 1.06) | 26.91 |
Site | gen | LSS12 ERR0.025b | 2-p ERR0.025,φc | φmd | trans ERR0.025,φd | φmf |
Stomach | M/F | 0.00006 (0.000025, 0.0001) | 0.39 (0.08, 0.86) | 11.89 | 0.08 (-0.11, 0.23) | 11.85 |
M | 0.001 (-0.0005, 0.0028) | 2.43 (-0.23, 31.08) | 6.14 | 0.16 (-0.16, 0.47) | 21.77 | |
F | 0.0047 (0.0022, 0.0077) | 0.71 (0.05, 1.62) | 13.67 | 0.30 (0.01, 0.76) | 13.68 | |
Liver | M/F | 0.000093 (0.000033, 0.00016) | 1.10 (0.26, 2.37) | 36.90 | 0.77 (0.18, 1.67) | 36.90 |
M | 0.00012 (0.000043, 0.00022) | 1.30 (0.12, 3.50) | 36.97 | 1.25 (0.25, 3.00) | 36.97 | |
F | 0.000048 (-0.000028, 0.00016) | 1.03 (0.04, 2.94) | 36.90 | 0.43 (0.01, 1.46) | 38.55 | |
Lung | M/F | 0.00013 (0.00007, 0.00021) | 0.86 (0.14, 3.34) | 13.60 | 0.79 (0.20, 2.01) | 13.60 |
M | 0.000085 (0.000015, 0.00014) | 0.96 (-0.05, 5.39) | 13.55 | 0.92 (0.12, 2.92) | 13.55 | |
F | 0.00022 (0.0001, 0.00038) | 1.12 (0.08, 4.15) | 21.91 | 0.91 (0.10, 2.87) | 21.91 | |
Colon | M/F | 0.00017 (0.00006, 0.0003) | 0.25 (-0.44, 1.46) | 20.28 | 0.58 (-0.25, 1.85) | 43.98 |
M | 0.00012 (-0.000005, 0.00032) | 0.65 (-0.45, 4.34) | 28.63 | 0.72 (-0.30, 3.72) | 28.63 | |
F | 0.0002 (0.000055, 0.00019) | 0.94 (-0.21, 3.17) | 41.62 | 0.85 (-0.15, 2.56) | 41.62 | |
Uterus | F | 0.00006 (-0.000015, 0.00017) | 0.66 (-0.10, 2.44) | 26.91 | 0.25 (-0.09, 1.13) | 26.91 |
a Life Span Study Report 12 [4]
b from LSS12 Tables AII, AIII and AIV, scaled by the linear assumption ERR1 = ERR per 10 mSv = 0.01(ERR per Sv) and ERR0.025 = 0.00025(ERR per Sv)
c Two-phase model fitted to 0 – 20 mSv subcohort at optimal latency (see also Table 3 for M/F results)
d Optimal latency for Two-phase model on 0 – 20 mSv subcohort
e Transient model at fitted to 0 – 20 mSv subcohort at optimal latency (see also Table 2 for M/F results)
f Optimal latency for Transient model on 0 – 20 mSv subcohort